Peptide - peptoid hybrids based on (1-11)-parathyroid hormone analogs

Journal of Peptide Science

Volumn 16, Issue 9, 2010, Pages 480-485

  Caporale, A ^a   Schievano, E ^a   Peggion, E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bioactivities; Conformation; N substituted glycine; Peptidomimetics; PTH analogs

Indexed keywords

HISTIDYLALANYLNORVALYLALPHAAMINOISOBUTYRICACIDGLUTAMYLISOLEUCYLGLYCYLLEUCYLNORLEUCYLHISTIDYLGLYCYLHOMOARGINYLAMIDE; HISTIDYLALPHAAMINOISOBUTYRICACIDVALYLALPHAAMINOISOBUTYRICACIDGLUTAMYLISOLEUCYLGLYCYLLEUCYLNORLEUCYLHISTIDYLGLYCYLARGINYLAMIDE; HISTIDYLALPHAAMINOISOBUTYRICACIDVALYLALPHAAMINOISOBUTYRICACIDGLUTAMYLISOLEUCYLGLYCYLLEUCYLNORLEUCYLHISTIDYLGLYCYLHOMOARGINYLAMIDE; HISTIDYLALPHAAMINOISOBUTYRICACIDVALYLALPHAAMINOISOBUTYRICACIDGLUTAMYLISOLEUCYLGLYCYLLEUCYLNORNORLEUCYLHISTIDYLGLYCYLHOMOARGINYLAMIDE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE RECEPTOR 1; PEPTOID; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; PRIORITY JOURNAL; SYNTHESIS;

HEK293 CELLS; HUMANS; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PEPTOIDS; RECEPTOR, PARATHYROID HORMONE, TYPE 1;

EID: 77957315565     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1265     Document Type: Article

References (48)

1. Adessi C, Soto C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr. Med. Chem. 2002; 9: 963-978.
2. Vagner J, Qu H, Hruby VJ. Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 2008; 12: 292-296.
3. Hruby VJ. Designing peptide receptor agonists and antagonists. Nat. Rev. Drug Discov. 2002; 1: 847-858.
4. Holder JR, Bauzo RM, Xiang Z, Scott J, Haskell-Luevano C. Design and pharmacology of peptoids and peptide - peptoid hybrids based on the melanocortin agonists core tetrapeptide sequence. Bioorg. Med. Chem. Lett. 2003; 13: 4505-4509.
5. Vercillo OE, Andrade CKZ, Wessjohann LA. Design and synthesis of cyclic RGD pentapeptoids by consecutive Ugi reactions. Org. Lett. 2008; 10: 205-208.
6. Zuckermann RNK, Kerr JM, Kent SBH, Moos WH. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J. Am. Chem. Soc. 1992; 114: 10646-10647.
7. Simon RJ, Kania RS, Zuckermann RN, Huebner VD, Jewell DA, Banville S, Ng S, Wang L, Rosenberg S, Marlowe CK, Spellmeyer DC, Tan R, Frankel AD, Santi DV, Cohen FE, Bartlett PA. Peptoids: a modular approach to drug discovery. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 9367-9371.
8. Schröder T, Niemeier N, Afonin S, Ulrich AS, Krug HF, Bräse S. Peptoidic amino- and guanidinium-carrier systems: targeted drug delivery into the cell cytosol or the nucleus. J. Med. Chem. 2008; 51: 376-379.
9. Kessler H. Peptoids: a new approach to the development of pharmaceuticals. Angew. Chem. Int. Ed. Engl. 1993; 32: 543-544.
10. Messeguer J, Cortes N, Garcja-Sanz N, Navarro-Vendrell G, Ferrer- Montiel A, Messeguer A. Synthesis of positional scanning library of pentamers of N-alkylglycines assisted by microwave activation and validation via the identification of trypsin inhibitors. J. Comb. Chem. 2008; 10: 974-980 and references therein.
11. Edwards P. Peptoid positional scanning libraries for identification of multidrug resistance reversal agents. Drug Discov. Today 2006; 11: 669-670. (Pubitemid 43912498)
12. Goodman M, Bhumralkar M, Jefferson EA, Kwak J, Locardi E. Collagen mimetics. Biopolymers 1998; 47: 127-142.
13. Heizmann G, Hildebrand P, Tanner H, Ketterer S, Pansky A, Froidevaux S, Beglinger C, Eberle AN. A combinatorial peptoid library for the identification of novel MSH and GRP/bombesin receptor ligands. J. Recept. Signal Transduct. Res. 1999; 19: 449-466.
14. Zuckermann RN, Martin EJ, Spellmeyer DC, Stauber GB, Shoemaker KR, Kerr JM, Figliozzi GM, Goff DA, Siani MA, Simon RJ, Banville SC, Brown EG, Wang L, Richter LS, Moos WH. Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. J. Med. Chem. 1994; 37: 2678-2685.
15. Kruijtzer JAW, Nijenhuis WAJ, Wanders N, Gispen WH, Liskamp RMJ, Adan RAH. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands. J.Med. Chem. 2005; 48: 4224-4230.
16. Humet M, Carbonell T, Masip I, Sánchez-Baeza F, Mora P, Cantón E, Gobernado M, Abad C, Pérez-Payá E, Messeguer A. A positional scanning combinatorial library of peptoids as a source of biological active molecules: identification of antimicrobials. J. Comb. Chem. 2003; 5: 597-605.
17. Udugamasooriya DG, Dineen SP, Brekken RA, Kodadek T. A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity. J. Am. Chem. Soc. 2008; 130: 5744-5752.
18. Roy O, Faure S, Thery V, Didierjean C, Taillefumier C. Cyclic β-peptoids. Org. Lett. 2008; 10: 921-924.
19. Diaz-Mochon JJ, Fara MA, Sanchez-Martin RM, Bradley M. Peptoid dendrimers - microwave-assisted solid-phase synthesis and transfection agent evaluation. Tetrahedron Lett. 2008; 49: 923-926.
20. Ruijtenbeek R, Kruijtzer JAW, van de Wiel W, Fischer MJE, Flück M, Redegeld FAM, Liskamp RMJ, Nijkamp FP. Peptoid-peptide hybrids that bind Syk SH2 domains involved in signal transduction. ChemBioChem 2001; 2: 171-179.
21. Fowler SA, Stacy DM, Blackwell HE. Design and synthesis of macrocyclic peptomers as mimics of quorum sensing signal from Staphylococcus. Org. Lett. 2008; 10: 2329-2332.
22. Shimizu N, Guo J, Gardella TJ. Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J. Biol. Chem. 2001; 276: 49003-49012.
23. Barazza A, Wittelsberger A, Fiori N, Schievano E, Mammi S, Toniolo C, Alexander JM, Rosenblatt M, Peggion E, Chorev M. Bioactive N-terminal undecapeptides derived from parathyroid hormone: the role of alpha-helicity. J. Pept. Res. 2005; 65: 23-35.
24. Potts JT, Gardella TJ. Progress, paradox, and potential parathyroid hormone research over five decades. Ann. N. Y. Acad. Sci. 2007; 1117: 196-208.
25. Gardella TJ, Jüppner H. Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol. Metab. 2001; 5: 210-217.
26. Scian M, Marin M, Bellanda M, Tou L, Alexander JM, Rosenblatt M, Chorev M, Peggion E, Mammi S. Backbone dynamics of human parathyroid hormone (1-34): flexibility of the central region under different environmental conditions. Biopolymers 2006; 84: 147-160.
27. Monticelli L, Mammi S, Mierke DF. Molecular characterization of a ligand-tethered parathyroid hormone receptor. Biophys. Chem. 2002; 95: 165-172.
28. Shimizu M, Potts JT Jr, Gardella TJ. Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J. Biol. Chem. 2000; 275: 21836-21843.
29. Shimizu M, Carter PH, Khatri A, Potts JT Jr, Gardella TJ. Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions. Endocrinology 2001; 142: 3068-3074. (Pubitemid 32575545)
30. Tsomaia N, Pellegrini M, Hyde K Gardella TJ, Mierke DF. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues. Biochemistry 2004; 43: 690-699.
31. Shimizu M, Petroni BD, Khatri A, Gardella TJ. Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues. Biochemistry 2003; 42: 2282-2290.
32. Caporale A, Biondi B, Schievano E, Wittelsberger A, Mammi S, Peggion E. Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids. Eur. J. Pharmacol. 2009; 611: 1-7.
33. Fiori N, Caporale A, Schievano E, Mammi S, Geyer A, Tremmel P, Wittelsberger A, Woznica I, Chorev M, Peggion E. Structure-function relationship studies of PTH(1-11) analogues containing sterically hindered dipeptide mimetics. J. Pept. Sci. 2007; 13: 504-512.
34. Kruijtzer JAW, Hofmeyer LJF, Heerma W, Versluis C, Liskamp RMJ. Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro)peptoids of Leuenkephalin and substance P. Chem. Eur. J. 1998; 4: 1570-1580.
35. Uno T, Beausoleil E, Goldsmith RA, Levine BH, Zuckermann RN. New submonomers for poly N-substituted glycines (peptoids). Tetrahedron Lett. 1999; 40: 1475-1478. (Pubitemid 29079404)
36. Carpino LA, El-Faham A, Albericio F. Efficiency in peptide coupling: 1- hydroxy-7-azabenzotriazole vs 3,4-dihydro-3-hydroxy-4-oxo-1,2,3- benzotriazine. J. Org. Chem. 1995; 60: 3561-3564;
37. Carpino LA, El-Faham A. Effect of tertiary bases on O- benzotriazolyluronium salt-induced peptide segment coupling. J. Org. Chem. 1994; 59: 695-698;
38. Carpino LA. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. J. Am. Chem. Soc. 1993; 115: 4397-4398.
39. Yang JT, Wu CS, Martinez HM. Calculation of protein conformation from circular dichroism. Methods Enzymol. 1986; 130: 208-269.
40. Rance M, Sørensen OW, Bodenhausen G, Wagner G, Ernst RR, Wüthrich K. Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983; 117: 479-485.
41. Griesinger C, Otting G, Wüthrich K, Ernst RR. Clean TOCSY for proton spin system identification in macromolecules. J.Am.Chem.Soc. 1988; 110: 7870-7872.
42. Caporale A, Woznica I, Schievano E, Mammi S, Peggion E. Role of the Guanidine group in the N-terminal fragment of PTH(1-11). Amino Acids 2010; 4: 1269-1275.
43. Lim S-K, Lee EJ, Kim H-Y, Lee W. The 10th and 11th residues of short length N-terminal PTH(1-12) analogue are important for its optimum potency. J. Pept. Res. 2004; 64: 25-32.
44. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 1998; 31: 297-355.
45. 10-helix/ α-helix transition: critical main-chain length. Biopolymers 2008; 90: 567-574.
46. Greenfield N, Fasman GD. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 1969; 8: 4108-4116.
47. Richardson JS. The anatomy and taxonomy of protein structure. Adv. Protein Chem. 1981; 34: 167-339.
48. de Haan EC, Wauben MHM, Grosfeld-Stulemeyer MC, Kruijtzer JAW, Liskamp RMJ, Moret EE. Major histocompatibility complex class II binding characteristics of peptoid - peptide hybrids. Bioorg. Med. Chem. 2002; 10: 1939-1945.